Study of Verbal Communication in People with ALS and Age-Matched Adults
Using Structured and Unstructured Speech Tasks
Led by Penn State University · Updated on 2026-08-07
300
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to understand how communicative interaction affects verbal communication in people with amyotrophic lateral sclerosis ALS compared to age-matched adults. The study explores differences in speech production across various tasks to clarify the impact of ALS-related speech difficulties. It is designed as a single-group study involving both people with ALS and age-matched speakers.
Participants will complete one solo speech production task and three interactive tasks involving structured and unstructured communicative interactions, using tablets and audio recording devices at home. They will work with unfamiliar interlocutors during these tasks, which include reading words and sentences with instructions to overenunciate in some cases. Speech will be recorded both locally and remotely via videoconferencing.
During the study, participants will perform speech tasks in sessions lasting about 60 minutes each. Researchers will analyze speech features such as formant frequencies, intelligibility, syntactic and pragmatic properties, and speech sound duration. The study uses statistical models to assess effects and variability, with participation expected to involve remote guidance and feedback over the course of the sessions.
CONDITIONS
Brief Title
Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications
Research Team
A
Anne Olmstead, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Structured/clear‑speech interaction (trial)
Usual behavioral and AAC strategies (context)
What it is
A single‑group study evaluating structured and unstructured communicative tasks with clear‑speech conditions involving a listener and speaker, both including people with ALS and matched or unfamiliar interlocutors
Established behavioral compensatory techniques and augmentative communication supports used in ALS communication care
Primary use
To assess how structured, clear‑speech and interaction tasks affect speech intelligibility and communication properties in ALS
To support intelligibility and communication for people with ALS using known behavioral adjustments and speech‑generating or low‑tech tools
Evidence status
Efficacy under investigation within this trial; outcomes not yet reported
Behavioral strategies and AAC have demonstrated usefulness for mild to moderate dysarthria and support communication when speech declines
Important limitations
Single‑group design without a control arm limits comparative inference
Evidence for behavioral and AAC strategies in ALS communication is limited by small studies and intervention heterogeneity
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 90Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Diagnosis of amyotrophic lateral sclerosis (ALS) following the revised EL Escorial criteria
No history of other neurological conditions such as stroke
No cognitive impairment as assessed by Telephone Montreal Cognitive Assessment (mini MoCA)
Detectable speech disturbance according to the ALS Functional Rating Scale-Revised (ALSFRS-R)
Ability to produce single words
Native speaker of American English
Age between 18 and 90 years
Passing remote hearing screening for age-matched speakers and unfamiliar interlocutors
No known speech, language, or neurological disorders for age-matched speakers and unfamiliar interlocutors
No experience communicating with people with dysarthria for unfamiliar interlocutors
Functionally native monolingual speaker of American English for age-matched speakers and unfamiliar interlocutors
You will not qualify if you...
None if all inclusion criteria are met
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 remote screening visit via videoconferencing
Speech Task Sessions
Duration - Several sessions lasting about 60 minutes each
Participants complete speech tasks including solo reading and interactive communication exercises with unfamiliar partners using tablets and audio recorders at home.
Remote sessions conducted via videoconferencing
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Similar Trials
Long-Term Safety and Tolerability Study of LY4256984 in Adults With Amyotrophic Lateral Sclerosis Within a Master Protocol Design
Study Comparing Individualized Physiotherapy to Standard Care for People with Amyotrophic Lateral Sclerosis ALS
Observing the Natural Course and Genetic Factors of Amyotrophic Lateral Sclerosis in Chinese Patients
Evaluating Intrathecal LTX-002 Versus Placebo in Adults With Amyotrophic Lateral Sclerosis Using Multiple Dose Levels
Study of Ranolazine to Assess Safety and Impact on Muscle Cramps, Function, and Quality of Life in Adults with ALS
Randomized Double-Blind Study of Darifenacin Safety and Effects in Adults with Amyotrophic Lateral Sclerosis
Phase 1 Study of RAG-17 Safety and Effects in Adults with ALS and SOD1 Gene Mutation
Investigating the Safety and Pharmacodynamics of a Single Intrathecal Injection of INS1202 in Adults with Amyotrophic Lateral Sclerosis
Evaluating Safety, Tolerability, and Effects of Intrathecal BIIB147 Compared to Placebo in Adults with Amyotrophic Lateral Sclerosis with an Open-Label Extension
Long-Term Safety Study of Tofersen Qalsody in Adults with SOD1 Mutation Amyotrophic Lateral Sclerosis ALS
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The Role of the Speaker, the Listener, and Their Joint Contributions During Communicative Interactions: A Tripartite View of Intelligibility in Individuals With Dysarthria.